Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray), 0.03% ...

Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray) 0.03% Lupin and Natco Receive Approval from U. S. FDA for Bosentan Tablets for Oral Suspension. Intimation ...

Shares of Vodafone Idea, SAIL, IRCTC, Tata Investment and Ircon will be in focus as the companies will announce their third ...

Stocks including Eicher Motors, Lupin, MTAR Technologies, Aditya Birla Capital, Nykaa, Bata india, SBFC Finance, Samhi Hotels ...

OKAY, HONEY, COME SIT HERE. TODAY, JOE IS TESTING SOMETHING NEW. A MEDICATION CALLED FOR INSIDE THIS NASAL SPRAY. ONE, TWO. THREE. JOE IS THE FIRST PATIENT WITH ALZHEIMER’S TO TRY THIS DRUG.